The infamous Colombian “drug lord” of the past has been replaced by the savvy and respected businessman of the future.
Anthony Wile is the Canadian born and bred entrepreneur, business strategist, author and global market investor who also is the prescient chief executive of Toronto-based PharmaCielo Ltd. Five years ago, at the same time as he completed his book, “Financial Freedom,” he determined that legalized cannabis was on the cusp of explosive global growth. From that recognition, he took the lead in reshaping Colombia’s position in the marketplace.
Having done substantial business in Colombia, Anthony Wile recognized that the Latin American nation was in an ideal position to capitalize on the cannabis market, given a climate that, in every respect, was ideal. In addition to the ideal, year-round growing conditions in this equatorial country, a forward-thinking new government was in place to set the right direction from a regulatory, economic and business perspective.
Colombia’s legalization of medical cannabis for domestic use and import puts it in a strong position to grow into owning a fifth of a potential $40 billion global market.
Wile backed his confidence in Colombia’s future role with advocacy, starting with flower growers. Colombia is the leading flower-producing nation, and growers already had an infrastructure in place, Wile believed, to support the nascent industry. The cost structure of growing in this region would be 5-cents per gram versus the $1.50 when grown in northern greenhouses.
He put his money where his mouth was, too, partnering with a long-time leader of the Colombian flower industry to launch PharmaCielo. PharmaCielo, or “medicine from the heavens”, would set the standards for quality product and business practices.
Then, he began advocating with investors on the company’s opportunity to be a leading producer of quality medical cannabis. PharmaCielo has raised approximately $100 million among investors to advance growth in Colombia as it readies to go public on the Toronto Stock Exchange.
“The way I see it,” Anthony Wile says, “a Canadian-Colombian venture would be a winning combination in order to win a significant share of this growing business. Canada has been an innovative leader in developing a carefully regulated medical cannabis industry. And Colombia has the idea conditions in climate, economy and people for growing according to our shared high standards.”
In late 2017, Colombia’s legislation and regulations legalizing medicinal cannabis became effective. PharmaCielo became the first company to be licensed to grow and process the plant, and holds the largest amount of acreage, outside the city of Medellin that once was the base of notorious drug lord Pablo Escobar. A second site in Colombia’s Cauca region hosts a joint venture whose proceeds are earmarked for the local community.
“We share with the government the understanding that thriving local economies are essential as the backbone to a healthy national economy,” Wile explains. “Our Cauca operation is the first of many we have planned to help boost communities that were hurt most by the civil unrest of the past.”
Anthony Wile’s role advancing the business and economic prospects of Colombia and its people have not gone unrecognized. In August, the Nova Scotia native who is fluent in Spanish and English, became a citizen of Colombia. The honor, conferred by special presidential decree, recognizes his contributions to bringing Canada and Colombia together, now with dual citizenship in both.
Candriam excludes 40 percent of all emerging markets
In a report, Bloomberg has used the Candriam SRI Bond Emerging Markets Fund as an example of how active fund...
What is the scope of the CFA franc reform in West Africa
The monetary system of the CFA franc zone, in general, is increasingly challenged, with France being accused of still maintaining...
Europe’s stock exchanges are in an optimal window to buy, says analyst
The declines of more than 3% during some moments of the session led the main stock markets of the Old...
The fintech company Joonko to cease operations after only 12 months of existence
The October 28th press release published by Joonko stated that the Series A financing round with existing and new investors,...
Asabys Partners leads a round of $20 million in Sidekick
Asabys has recently led a successful round of financing in Sidekick, a company specialized in digital therapies. This round will...
Featured7 days ago
Savills IM refinances two Italian assets with one of the first green loans in Italy
Business7 days ago
4 tips to market your small business locally
Business6 days ago
Major reasons why your website might not be attracting customers
Biotech6 days ago
Roche signs its new diabetes business manager in Spain to Isdin